Stay updated on Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page.

Latest updates to the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations section added with Georgia; HHS Vulnerability Disclosure and Georgia Locations labels removed; revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved the government funding status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedScreenshots show only minor UI/layout updates and duplicated sections, with no changes to core trial data such as status, enrollment, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange Detected- Added a prominent operating-status notice and link guidance for NIH Clinical Center, and a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check91 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & IRX-2 in Oral/HPV Cancer Surgery Clinical Trial page.